Document is current
Any future updates will be listed below
-
Authors
Fawsitt, Christopher G.
Pan, Janice
Orishaba, Philip
Jackson, Christopher H.
Thom, Howard
-
Funding
Funding for this research was provided by:
Eisai Incorporated
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 20 January 2025
First Online: 30 January 2025
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CGF and PO are employees of Clifton Insight. HT holds stock in Clifton Insight. CHJ has received personal consulting fees from Clifton Insight. JP is an employee of Eisai. Clifton Insight has received consulting fees from Eisai, Pfizer, Novartis, Roche, Bayer, Lundbeck, Argenx, BMS, Merck, UCB, Amicus, Taiho, and Daiichi Sankyo.
